NGNE
Neurogene, Inc. Common Stock
$22.08
-7.59%
-1.82
Notify me if price changes either direction
Buy NGNE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
342.8M
Enterprise value
115.2M
Trailing PE
-5.1542054826968
Forward PE
-4.566515
PEG Ratio
0.30667522622046
Enterprise to EBITDA
-1.222
Enterprise to revenue
124.49634594595
Price to book MRQ
1.2558424
Price to sales TTM
370.58299891892
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
925.0K
EBITDA
-94208000
Diluted EPS TTM
-4.1
Total Cash (MRQ)
265.4M
Current ratio (MRQ)
18.39
Operating Cash Flow (TTM)
-77240000
NGNE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
